» Articles » PMID: 9275164

Phylogeny of MRNA Capping Enzymes

Overview
Specialty Science
Date 1997 Sep 2
PMID 9275164
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

The m7GpppN cap structure of eukaryotic mRNA is formed cotranscriptionally by the sequential action of three enzymes: RNA triphosphatase, RNA guanylyltransferase, and RNA (guanine-7)-methyltransferase. A multifunctional polypeptide containing all three active sites is encoded by vaccinia virus. In contrast, fungi and Chlorella virus encode monofunctional guanylyltransferase polypeptides that lack triphosphatase and methyltransferase activities. Transguanylylation is a two-stage reaction involving a covalent enzyme-GMP intermediate. The active site is composed of six protein motifs that are conserved in order and spacing among yeast and DNA virus capping enzymes. We performed a structure-function analysis of the six motifs by targeted mutagenesis of Ceg1, the Saccharomyces cerevisiae guanylyltransferase. Essential acidic, basic, and aromatic functional groups were identified. The structural basis for covalent catalysis was illuminated by comparing the mutational results with the crystal structure of the Chlorella virus capping enzyme. The results also allowed us to identify the capping enzyme of Caenorhabditis elegans. The 573-amino acid nematode protein consists of a C-terminal guanylyltransferase domain, which is homologous to Ceg1 and is strictly conserved with respect to all 16 amino acids that are essential for Ceg1 function, and an N-terminal phosphatase domain that bears no resemblance to the vaccinia triphosphatase domain but, instead, has strong similarity to the superfamily of protein phosphatases that act via a covalent phosphocysteine intermediate.

Citing Articles

Emerging prospects of mRNA cancer vaccines: mechanisms, formulations, and challenges in cancer immunotherapy.

Laila U, An W, Xu Z Front Immunol. 2024; 15:1448489.

PMID: 39654897 PMC: 11625737. DOI: 10.3389/fimmu.2024.1448489.


mRNA melanoma vaccine revolution spurred by the COVID-19 pandemic.

Xu Z, Fisher D Front Immunol. 2023; 14:1155728.

PMID: 37063845 PMC: 10101324. DOI: 10.3389/fimmu.2023.1155728.


Capping Enzyme mRNA-cap/RNGTT Regulates Hedgehog Pathway Activity by Antagonizing Protein Kinase A.

Chen P, Zhou Z, Yao X, Pang S, Liu M, Jiang W Sci Rep. 2017; 7(1):2891.

PMID: 28588207 PMC: 5460166. DOI: 10.1038/s41598-017-03165-2.


Molecular basis for specific viral RNA recognition and 2'-O-ribose methylation by the dengue virus nonstructural protein 5 (NS5).

Zhao Y, Soh T, Pheng Lim S, Chung K, Swaminathan K, Vasudevan S Proc Natl Acad Sci U S A. 2015; 112(48):14834-9.

PMID: 26578813 PMC: 4672796. DOI: 10.1073/pnas.1514978112.


Predicted structure and domain organization of rotavirus capping enzyme and innate immune antagonist VP3.

Ogden K, Snyder M, Dennis A, Patton J J Virol. 2014; 88(16):9072-85.

PMID: 24899176 PMC: 4136241. DOI: 10.1128/JVI.00923-14.


References
1.
Nishikawa Y, Chambon P . Purification of mRNA guanylyltransferase from calf thymus. EMBO J. 1982; 1(4):485-92. PMC: 553072. DOI: 10.1002/j.1460-2075.1982.tb01195.x. View

2.
Yagi Y, Mizumoto K, Kaziro Y . Association of an RNA 5'-triphosphatase activity with RNA guanylyltransferase partially purified from rat liver nuclei. EMBO J. 1983; 2(4):611-5. PMC: 555069. DOI: 10.1002/j.1460-2075.1983.tb01471.x. View

3.
Mizumoto K, Kaziro Y . Messenger RNA capping enzymes from eukaryotic cells. Prog Nucleic Acid Res Mol Biol. 1987; 34:1-28. DOI: 10.1016/s0079-6603(08)60491-2. View

4.
Shibagaki Y, Itoh N, Yamada H, Nagata S, Mizumoto K . mRNA capping enzyme. Isolation and characterization of the gene encoding mRNA guanylytransferase subunit from Saccharomyces cerevisiae. J Biol Chem. 1992; 267(14):9521-8. View

5.
Pena L, Yanez R, Revilla Y, Vinuela E, Salas M . African swine fever virus guanylyltransferase. Virology. 1993; 193(1):319-28. DOI: 10.1006/viro.1993.1128. View